91 related articles for article (PubMed ID: 1322577)
1. [Chromosomal restructurings and the distribution of chromosome fragile sites in the peripheral blood lymphocytes in a breast cancer patient after cytostatic therapy].
Iakovleva TK; Monakhov AS; Moiseenko VM
Tsitologiia; 1992; 34(2):77-83. PubMed ID: 1322577
[TBL] [Abstract][Full Text] [Related]
2. Common fragile sites: their prevalence in subjects with constitutional and acquired chromosomal instability.
Tedeschi B; Porfirio B; Vernole P; Caporossi D; Dallapiccola B; Nicoletti B
Am J Med Genet; 1987 Jun; 27(2):471-82. PubMed ID: 3111262
[TBL] [Abstract][Full Text] [Related]
3. [The determination of chromosome fragile sites in the peripheral blood lymphocytes of patients with colorectal cancer taking into account the cancer pathology predisposition in the familial anamnesis].
Nesina IP; Polishchuk LZ; Oliĭnichenko PI
Tsitol Genet; 2000; 34(1):3-9. PubMed ID: 10808535
[TBL] [Abstract][Full Text] [Related]
4. [Chromosome fragile sites in patients with multiple primary tumors and familial forms of breast cancer].
Kuleshov NP; Cortina-Guerrero GD; Razinkova GA; Gar'kavtseva RF; Nefedov MD; Kuzina NIu; Letiagin VP
Vopr Onkol; 1992; 38(2):160-6. PubMed ID: 1300700
[TBL] [Abstract][Full Text] [Related]
5. Chromosomal abnormalities in women with breast cancer after autologous stem cell transplantation are infrequent and may not predict development of therapy-related leukemia or myelodysplastic syndrome.
Martínez-Climent JA; Comes AM; Vizcarra E; Benet I; Arbona C; Prósper F; Solano C; García Clavel B; Marugán I; Lluch A; García-Conde J
Bone Marrow Transplant; 2000 Jun; 25(11):1203-8. PubMed ID: 10849534
[TBL] [Abstract][Full Text] [Related]
6. Expression of aphidicolin-induced fragile sites and their relationship between genetic susceptibility in breast cancer, ovarian cancer, and non-small-cell lung cancer patients.
Dhillon VS; Husain SA; Ray GN
Teratog Carcinog Mutagen; 2003; Suppl 1():35-45. PubMed ID: 12616595
[TBL] [Abstract][Full Text] [Related]
7. Chromosomal fragile site expression in dogs: I. Breed specific differences.
Stone DM; Jacky PB; Hancock DD; Prieur DJ
Am J Med Genet; 1991 Aug; 40(2):214-22. PubMed ID: 1910263
[TBL] [Abstract][Full Text] [Related]
8. [Ablative hormone therapy and chemotherapy of metastatic breast cancer].
Kasch R; Gerber B; Blaschke U
Zentralbl Gynakol; 1989; 111(23):1584-7. PubMed ID: 2560303
[TBL] [Abstract][Full Text] [Related]
9. [Fragile sites of cultured peripheral blood lymphocyte chromosomes in patients with gestational trophoblastic tumor].
Xu C
Zhonghua Fu Chan Ke Za Zhi; 1990 May; 25(3):159-61, 189. PubMed ID: 2167825
[TBL] [Abstract][Full Text] [Related]
10. Expression of folate sensitive and aphidicolin induced chromosomal fragile sites in familial neuroblastoma.
Ankathil R; Kusumakumary P; Priyakumary T; Krishnan Nair M
J Exp Clin Cancer Res; 2002 Sep; 21(3):383-8. PubMed ID: 12385582
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous unusual expression of frequency of chromosome aberrations and common fragile in human lymphocytes of colorectal cancer patients induced by Aphidicolin.
Saxena AK; Agarwal CS; Kumar M; Srivastava AK; Singh G
J Exp Ther Oncol; 2007; 6(2):175-9. PubMed ID: 17407975
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the genotoxicity of atenolol in human peripheral blood lymphocytes: correlation between chromosomal fragility and content of micronuclei.
Télez M; Ortiz-Lastra E; Gonzalez AJ; Flores P; Huerta I; Ramírez JM; Barasoain M; Criado B; Arrieta I
Mutat Res; 2010 Jan; 695(1-2):46-54. PubMed ID: 19932191
[TBL] [Abstract][Full Text] [Related]
13. [Preoperative intensive chemotherapy of operable breast cancer].
Zhang B
Zhonghua Zhong Liu Za Zhi; 1989 May; 11(3):228-30. PubMed ID: 2558871
[TBL] [Abstract][Full Text] [Related]
14. Concurrent chemotherapy and radiation for breast conservation treatment of early-stage breast cancer.
Markiewicz DA; Fox KR; Schultz DJ; Harris EE; Haas JA; Glick JH; Solin LJ
Cancer J Sci Am; 1998; 4(3):185-93. PubMed ID: 9612601
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy.
Gasparini G; Toi M; Miceli R; Vermeulen PB; Dittadi R; Biganzoli E; Morabito A; Fanelli M; Gatti C; Suzuki H; Tominaga T; Dirix LY; Gion M
Cancer J Sci Am; 1999; 5(2):101-11. PubMed ID: 10198732
[TBL] [Abstract][Full Text] [Related]
16. 12q13 fragility in a family with recurrent spontaneous abortions: expression of the fragile site under different culture conditions.
Giardino D; Bettio D; Simoni G
Ann Genet; 1990; 33(2):88-91. PubMed ID: 2241090
[TBL] [Abstract][Full Text] [Related]
17. Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast.
Solin LJ; Fourquet A; Vicini FA; Haffty B; Taylor M; McCormick B; McNeese M; Pierce LJ; Landmann C; Olivotto IA; Borger J; de La Rochefordiere A; Schultz DJ
Cancer; 2001 Mar; 91(6):1090-7. PubMed ID: 11267953
[TBL] [Abstract][Full Text] [Related]
18. [Karyotypic anomalies and chromosomal sites of increased fragility in colorectal cancer].
Sokova OI; Kirichenko OP; Kulagina OE; Konstantinova LN; Chebotarev AN; Fleĭshman EV
Genetika; 1997 Sep; 33(9):1297-302. PubMed ID: 9445823
[TBL] [Abstract][Full Text] [Related]
19. [Clinical and histologic effects of preoperative combination chemotherapy of breast cancer].
Wang ZY
Zhonghua Wai Ke Za Zhi; 1988 Nov; 26(11):648-50, 700. PubMed ID: 2855506
[No Abstract] [Full Text] [Related]
20. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
Gasparini G; Barbareschi M; Doglioni C; Palma PD; Mauri FA; Boracchi P; Bevilacqua P; Caffo O; Morelli L; Verderio P
Clin Cancer Res; 1995 Feb; 1(2):189-98. PubMed ID: 9815973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
